References and Notes
<A NAME="RD32010ST-1">1</A>
Saibabu Koti SRS.
Timmons C.
Li G.
Chem. Biol. Drug Des.
2006,
67:
101
For recent examples, see:
<A NAME="RD32010ST-2A">2a</A>
Diaz-Valenzuela MB.
Philips SD.
France MB.
Gunn ME.
Clarke ML.
Chem. Eur. J.
2009,
15:
1227
<A NAME="RD32010ST-2B">2b</A>
Uchida T.
Katsuki T.
Tetrahedron Lett.
2009,
50:
4741
<A NAME="RD32010ST-2C">2c</A>
Fu X.
Loh W.-T.
Zhang Y.
Chen T.
Ma T.
Liu H.
Wang J.
Tan C.-H.
Angew.
Chem. Int. Ed.
2009,
48:
7387
<A NAME="RD32010ST-2D">2d</A>
Yang X.
Liu H.
Fu H.
Qiao R.
Jiang Y.
Zhao Y.
Synlett
2010,
101
For recent examples, see:
<A NAME="RD32010ST-3A">3a</A>
Sriramurthy V.
Barcan
GA.
Kwon O.
J.
Am. Chem. Soc.
2007,
129:
1298
<A NAME="RD32010ST-3B">3b</A>
Murai K.
Takaichi N.
Takahara Y.
Fukushima S.
Fujioka H.
Synthesis
2010,
520
<A NAME="RD32010ST-3C">3c</A>
Hari GS.
Lee YR.
Synthesis
2010,
453
<A NAME="RD32010ST-4">4</A>
Agrawal JP.
Hodgson RD.
Organic
Chemistry of Explosives
Wiley;
New
York:
2007.
<A NAME="RD32010ST-5">5</A>
Ledgard JB.
The Preparatory Manual of Explosives
3rd ed.:
Jared
Ledgard;
Washington:
2007.
<A NAME="RD32010ST-6">6</A>
Chilton WS.
Hsu ChP.
Phytochemistry
1975,
14:
2291
<A NAME="RD32010ST-7">7</A>
Miyazaki Y.
Kono Y.
Shimazu A.
Takeuchi S.
Yonehara H.
J. Antibiot.
1968,
21:
279
<A NAME="RD32010ST-8">8</A>
Bachmann WE.
Horton WJ.
Jenner EL.
MacNaughton NW.
Maxwell CE.
J. Am. Chem. Soc.
1950,
72:
3132
<A NAME="RD32010ST-9">9</A>
Krapcho AP,
Menta E,
Oliva A, and
Spinelli S. inventors; US 5519029.
; Chem. Abstr. 1994, 121, 157651
<A NAME="RD32010ST-10">10</A>
Astakhov M.
Stepanov RS.
Kruglyakova LA.
Kekin YV.
Russ.
J. Org. Chem.
2000,
36:
575
<A NAME="RD32010ST-11">11</A>
Procedure for
the Preparation of 1,3-Bis[2-(nitroamino)-ethyl]urea
(5)
Starting material 4 (2.0
g, 15.26 mmol) was suspended in H2O (10 mL). To this
suspension was added dropwise 10% NaOH (10 mL); the starting
material 4 dissolved. After 1 h stirring
at laboratory temperature the reaction mixture was acidified with
dilute HCl to pH 2. Product 5 crystallized from
this solution in 72% yield (1.3 g) as colorless crystals. C5H12N6O5 (236.18);
mp 161-163 ˚C. MS: m/z (rel. abundance) = 175.1
(14) [NO2NHCH2CH2NHCONHCH2CH2]+. ¹H
NMR (300 MHz, DMSO-d
6): δ = 3.16
(q, 4 H, J = 5.9
Hz, H4, H4′), 3.42 (t, 4 H, J = 5.9
Hz, H3, H3′), 6.19 (t, 2 H, J = 5.9
Hz, NH-5, NH-5′), 11.98 (br s, 2 H, NH-2, NH-2′). ¹³C
NMR (75 MHz, DMSO-d
6): δ = 36.5,
45.5, 158.0.
<A NAME="RD32010ST-12">12</A>
Representative
Experimental Procedure for the Preparation of 1-(2-Hydroxyethyl)-3-[2-(nitroamino)-ethyl]urea
(31)
Starting material 4 (1.0
g, 7.63 mmol) was dissolved in MeOH (30 mL) and 2-aminoethanol (0.5
g, 8.18 mmol, 1.07 equiv) was added. The reaction mixture was heated
to boiling and periodically analyzed using TLC (mobile phase: EtOAc).
After 2 h the spot corresponding to 4 disappeared, the
reaction mixture was concentrated to crystallization, and the crude
product was filtered. Recrystallization from i-PrOH-toluene
afforded 31 as colourless crystals (1.18
g, 81%). C5H12N4O4 (192.17);
mp 101-103 ˚C. MS: m/z (%) = 131.0(16) [HO(CH2)2NHCONHCH2CH2]+. ¹H
NMR (300 MHz, DMSO-d
6): δ = 3.03
(q, 2 H, J = 5.6
Hz, H-8), 3.15 (q, 2 H, J = 5.8
Hz, H-4), 3.17-3.40 (m, 4 H, H-3, H-9), 4.73 (br s, 1 H,
OH), 6.03 (t, 1 H, J = 5.6
Hz, NH-7), 6.14 (t, 1 H, J = 5.8
Hz, NH-5), 11.0 (s, 1 H, NH-2). ¹³C
NMR, (75 MHz, DMSO-d
6): δ = 36.5,
42.0, 46.6, 61.1, 158.
Spectroscopic
Data for Selected Products1-[2-(Nitroamino)ethyl]urea
(6)
C3H8N4O3 (148.12);
mp 97-99 ˚C. MS: m/z (%) = 87.1
(100) [NH2CONHCH2CH2]+. ¹H
NMR (300 MHz, DMSO-d
6): δ = 3.14
(q, 2 H, J = 5.9
Hz, H-4), 3.41 (t, 2 H, J = 5.9
Hz, H-3), 5.57 (s, 2 H, NH2), 6.10 (t, 1 H, J = 5.5 Hz,
NH-5), 12.00 (s, 1 H, NH-2). ¹³C NMR
(75 MHz, DMSO-d
6): δ = 36.4,
45.7, 158.7.
N
-[2-(Nitroamino)ethyl]hydrazinecarboxamide
(34)
C3H9N5O3 (163.13);
mp 129-131 ˚C. MS: m/z (%) = 163.9 (2) [M + H+],
102.0(100) [NH2NHCONHCH2CH2]+. ¹H NMR
(300 MHz, DMSO-d
6): δ = 3.13-3.23
(m, 4 H, H-3, H-4), 5.96 (br s, 3 H, NH2, NH-7), 6.46
(br s, 1 H, NH-5), 7.04 (s, 1 H, NH-2). ¹³C
NMR (75 MHz, DMSO-d
6): δ = 37.55,
50.01, 160.33.
Methyl [2-(Nitroamino)ethyl]carbamate
(41)
C4H9N3O4 (163.13);
mp 86-87.5 ˚C. MS: m/z (%) = 163.7 (4) [M + H]+,
102.1 (100) [CH3OCONHCH2CH2]+. ¹H
NMR (300 MHz, DMSO-d
6): δ = 3.15
(q, 2 H, J = 5.98
Hz, H-4), 3.43 (t, 2 H, J = 6.00
Hz, H-3), 3.52 (s, 3 H, CH3), 7.25 (t, 1 H, J = 5.1 Hz,
NH-5), 12.00 (s, 1 H, NH-2). ¹³C NMR
(75 MHz, DMSO-d
6): δ = 37.57,
44.67, 51.36, 156.77.
S
-Phenyl [2-(Nitroamino)ethyl]thiocarbamate
(43)
C9H11N3O3S
(241.26); mp 109-111 ˚C. MS: m/z (%): 180 (53) [C6H5SCONHCH2CH2]+. ¹H
NMR (300 MHz, DMSO-d
6): δ = 3.30
(q, 2 H, J = 5.4
Hz, CH2), 3.47 (t, 2 H, J = 5.4 Hz,
CH2), 7.36-7.47 (m, 5 H, ArH), 8.46 (t, 1 H, J = 5.4 Hz, NH),
12.07 (br s, 1 H, NH). ¹³C NMR (300
MHz, DMSO-d
6): δ = 33.9,
37.9, 127.1, 128.8, 129.4, 134.8, 164.3.